Comparison of therapeutic effect of prostatan (nettle) and pumpkin extract in a patient with benign prostatic hyperplasia
Phase 3
Recruiting
- Conditions
- Benign prostatic hyperplasia.Enlarged prostate
- Registration Number
- IRCT20210602051475N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Age over 50 years old
Benign prostate enlargement
Administrative detention
Frequent urination
Exclusion Criteria
Existence of urological disease other than benign prostate enlargement
Need immediate surgical intervention for treatment
Use of BPH-related drugs (stimulants and aggravators) in the last six months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased PSA levels during treatment. Timepoint: In the times before the intervention (0), two weeks, four weeks and eight weeks after the intervention, the questionnaire will be filled in by the participants in the project. Method of measurement: World Standard Scale for Symptoms of Prostate Hyperplasia and Uflometry.
- Secondary Outcome Measures
Name Time Method